Hennion & Walsh Asset Management, Inc. Corcept Therapeutics Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 48,122 shares of CORT stock, worth $2.62 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
48,122
Previous 69,327
30.59%
Holding current value
$2.62 Million
Previous $3.21 Million
24.42%
% of portfolio
0.12%
Previous 0.16%
Shares
11 transactions
Others Institutions Holding CORT
# of Institutions
351Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$900 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$545 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$450 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$354 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$208 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.83B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...